New Concept of Small Molecules Interaction with Proteins – An Application to Potential COVID-19 Drugs

Irena Cosic, Drasko Cosic and Ivan Loncarevic

International Journal of Sciences, 2020, vol. 9, issue 09, 16-25

Abstract: With the huge demand for new effective drugs there is large need for computational methods capable of quick preselection of potential drugs before they are chemically and biologically tested. Particularly, with the latest outbreak of coronavirus SARS-CoV-2 causing COVID-19 pandemic, there is urgent need to preselect number of potential small molecule drugs that are already approved for other purposes and are clinically tested on infected people with variety of success. The already established Resonant Recognition Model (RRM) proposes that selectivity of biological interactions and functions between proteins, DNA/RNA, is based on resonant electromagnetic energy between interacting macromolecules at the specific frequency for the specific interaction/function. However, this approach cannot be applied for selective specific interactions between proteins and small molecules (potential drugs), as small molecules are not linear sequential molecules. Here, we extended the RRM model to small molecules interaction with proteins proposing that energy frequencies of free electrons in small molecules are the most relevant for their resonant recognition and interaction with proteins. This extended RRM model is firstly tested here with couple of natural examples to explain and support the model, following with application to already approved drugs, which are also potential COVID-19 drugs including remdesivir, chloroquine and hydroxychloroquine. This newly extended RRM model opens new avenues for biochemistry and pharmaceutical industry in analyzes of small molecule – protein interaction, and consequently in preselection of new drugs and drug design in general.

Keywords: Drug Design; Small Molecules; Resonant Energy; Bioelectromagnetism; Resonant Recognition Model; SARS-Cov-2; COVID-19; Hydroxychloroquine; Chloroquine; Remdesivir (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://www.ijsciences.com/pub/article/2390 (text/html)
https://www.ijsciences.com/pub/pdf/V92020092390.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adm:journl:v:9:y:2020:i:9:p:16-25

Ordering information: This journal article can be ordered from
https://www.ijsciences.com/payment_guide.php

DOI: 10.18483/ijSci.2390

Access Statistics for this article

More articles in International Journal of Sciences from Office ijSciences Alkhaer Publications Manchester M8 8XG England.
Bibliographic data for series maintained by Staff ijSciences ().